Invasive Group A Streptococcal Disease in Alberta, Canada (2000 to 2002)

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2005 Apr 9

PMID 15814984

Citations 21

Authors

Gregory J Tyrrell

Marguerite Lovgren

Bertha Kress

Karen Grimsrud

Affiliations

Soon will be listed here.

Abstract

Invasive group A streptococcal (iGAS) disease was placed under surveillance in Alberta in August 1999. The purpose of this study was to determine the incidence rates of iGAS infections throughout Alberta over a 3-year period (2000 to 2002) and to better understand the epidemiology of iGAS in this province. There were a total of 441 cases of invasive GAS disease over the 3 years examined (average population over 3 years, 3,055,765) and 47 deaths. The incidence in Alberta was 5.0 (2000), 5.7 (2001), and 3.8 (2002) per 100,000. The two main metropolitan regions (Edmonton and Calgary) had the majority of iGAS disease cases (305 cases), producing incidence rates of 4.8 (Edmonton) and 6.9 (Calgary) in 2000, 6.9 (Edmonton) and 6.6 (Calgary) in 2001, and 4.1 (Edmonton) and 3.9 (Calgary) in 2002, as well as deaths attributable to GAS (31 deaths). The three most prevalent M types were M1 (71 cases), M3 (52 cases), and MPT2967 (44 cases). With respect to age, the highest incidence rates occurred in those less than 1 year old (11.7 per 100,000) and those 65 years or older (11.5 per 100,000). Varicella virus infection preceded iGAS disease in 25% of children 8 years of age and under. A seasonal association was observed during the 3 years studied, with the highest number of cases occurring in the winter months and the lowest occurring during the summer months. The data for years 2000 and 2001 show that the metropolitan regions of Alberta experienced some of the highest incidence rates reported in North America in the past decade.

Citing Articles

Current scenario of recently rising up cases of invasive group A streptococcal (iGAS) infections in younger children in many European nations: clinical management and prospective counteracting measures - an update.

Chopra H, Islam M, Chandran D, Emran T, Rehman Mohammad E, Dhama K Int J Surg. 2023; 109(3):579-581.

PMID: 36906758 PMC: 10389224. DOI: 10.1097/JS9.0000000000000156.

Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis.

Sherwood E, Vergnano S, Kakuchi I, Bruce M, Chaurasia S, David S Lancet Infect Dis. 2022; 22(7):1076-1088.

PMID: 35390294 PMC: 9217756. DOI: 10.1016/S1473-3099(21)00672-1.

Invasive bacterial diseases in northern Canada, 1999 to 2018.

Huang G, Martin I, Tsang R, Demczuk W, Tyrrell G, Li Y Can Commun Dis Rep. 2021; 47(11):491-499.

PMID: 34880711 PMC: 8601277. DOI: 10.14745/ccdr.v47i11a09.

Genital Tract GAS Infection ISIDOG Guidelines.

Donders G, Greenhouse P, Donders F, Engel U, Paavonen J, Mendling W J Clin Med. 2021; 10(9).

PMID: 34068785 PMC: 8126195. DOI: 10.3390/jcm10092043.

Increasing Incidence of Invasive Group A Streptococcus Disease in First Nations Population, Alberta, Canada, 2003-2017.

Tyrrell G, Bell C, Bill L, Fathima S Emerg Infect Dis. 2021; 27(2):443-451.

PMID: 33496247 PMC: 7853581. DOI: 10.3201/eid2702.201945.

References

Svensson N, Oberg S, Henriques B, Holm S, Kallenius G, Romanus V . Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis. 2001; 32(6):609-14. DOI: 10.1080/003655400459504. View

de Azavedo J, Yeung R, Bast D, Duncan C, Borgia S, Low D . Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother. 1999; 43(9):2144-7. PMC: 89437. DOI: 10.1128/AAC.43.9.2144. View

Sharkawy A, Low D, Saginur R, Gregson D, Schwartz B, Jessamine P . Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis. 2002; 34(4):454-60. DOI: 10.1086/338466. View

Martin J, Green M, Barbadora K, Wald E . Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med. 2002; 346(16):1200-6. DOI: 10.1056/NEJMoa013169. View

OBrien K, Beall B, Barrett N, Cieslak P, Reingold A, Farley M . Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002; 35(3):268-76. DOI: 10.1086/341409. View

Chuang I, Van Beneden C, Beall B, Schuchat A . Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis. 2002; 35(6):665-70. DOI: 10.1086/342062. View

Tyrrell G, Lovgren M, Forwick B, Hoe N, Musser J, Talbot J . M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol. 2002; 40(12):4466-71. PMC: 154642. DOI: 10.1128/JCM.40.12.4466-4471.2002. View

Passaro D, Smitht D, Hett E, Reingold A, Daily P, Van Beneden C . Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99. Epidemiol Infect. 2003; 129(3):471-8. PMC: 2869908. DOI: 10.1017/s0950268802007823. View

Robinson K, Rothrock G, Phan Q, Sayler B, Stefonek K, Van Beneden C . Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis. 2003; 9(4):443-7. PMC: 2957982. DOI: 10.3201/eid0904.020369. View

10.

Factor S, Levine O, Schwartz B, Harrison L, Farley M, McGeer A . Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis. 2003; 9(8):970-7. PMC: 3020599. DOI: 10.3201/eid0908.020745. View

11.

Eriksson B, Norgren M, McGregor K, Spratt B, Henriques Normark B . Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin Infect Dis. 2003; 37(9):1189-93. DOI: 10.1086/379013. View

12.

McGregor J, Ott A, Villard M . An epidemic of "childbed fever". Am J Obstet Gynecol. 1984; 150(4):385-8. DOI: 10.1016/s0002-9378(84)80144-1. View

13.

Mastro T, Farley T, Elliott J, Facklam R, Perks J, Hadler J . An outbreak of surgical-wound infections due to group A streptococcus carried on the scalp. N Engl J Med. 1990; 323(14):968-72. DOI: 10.1056/NEJM199010043231406. View

14.

Viglionese A, Nottebart V, Bodman H, Platt R . Recurrent group A streptococcal carriage in a health care worker associated with widely separated nosocomial outbreaks. Am J Med. 1991; 91(3B):329S-333S. DOI: 10.1016/0002-9343(91)90391-a. View

15.

Hoge C, Schwartz B, Talkington D, Breiman R, MacNeill E, Englender S . The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993; 269(3):384-9. View

16.

. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA. 1993; 269(3):390-1. View

17.

Colman G, Tanna A, Efstratiou A, Gaworzewska E . The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol. 1993; 39(3):165-78. DOI: 10.1099/00222615-39-3-165. View

18.

Stevens D . Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J. 1994; 13(6):561-6. DOI: 10.1097/00006454-199406000-00033. View

19.

Chelsom J, Halstensen A, Haga T, Hoiby E . Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet. 1994; 344(8930):1111-5. DOI: 10.1016/s0140-6736(94)90629-7. View

20.

Davies H, McGeer A, Schwartz B, Green K, Cann D, Simor A . Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996; 335(8):547-54. DOI: 10.1056/NEJM199608223350803. View